Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome
about
Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV InfectionsThe interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways.The role of KIR and HLA interactions in pregnancy complications.Higher expression of inhibitory CD158b and CD158e NK cell receptor and age predicts treatment response in children with chronic hepatitis C.
P2860
Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Diversity of killer cell immun ...... iants in HCV treatment outcome
@ast
Diversity of killer cell immun ...... iants in HCV treatment outcome
@en
type
label
Diversity of killer cell immun ...... iants in HCV treatment outcome
@ast
Diversity of killer cell immun ...... iants in HCV treatment outcome
@en
prefLabel
Diversity of killer cell immun ...... iants in HCV treatment outcome
@ast
Diversity of killer cell immun ...... iants in HCV treatment outcome
@en
P2093
P2860
P50
P1433
P1476
Diversity of killer cell immun ...... iants in HCV treatment outcome
@en
P2093
Antonio López-Vázquez
Jesús Martínez-Borra
Juan de la Vega
Luis Rodrigo
Paloma Sanz-Cameno
Ramón Pérez-Álvarez
Rosa Pérez-López
P2860
P304
P356
10.1371/JOURNAL.PONE.0099426
P407
P577
2014-06-13T00:00:00Z